Somatostatin receptor imaging (SRI) with [111In-DTPA0] octreotide has proven its role in
the diagnosis and staging of gastroenteropancreatic neuroendocrine tumors (GEPNETs). …

In this review we describe a transient type of gas discharge which is commonly called a
streamer discharge, as well as a few related phenomena in pulsed discharges. Streamers are …

Abstract Treatment with radiolabelled somatostatin analogues is a promising new tool in the
management of patients with inoperable or metastasized neuroendocrine tumours. …

Purpose There are few treatment options for patients with metastasized or inoperable endocrine
gastroenteropancreatic (GEP) tumors. Chemotherapy can be effective, but the response …

Medical treatment and chemotherapy are seldom successful in achieving objective tumour
reduction in patients with metastatic neuroendocrine tumours. Treatment with the …

Purpose: Bronchial and gastroenteropancreatic neuroendocrine tumors (NET) are slow-growing
tumors, which frequently express somatostatin receptors on their cell membranes. …

The organic photovoltaics field is maturing and reaching a technology readiness level where
the focus is on developing large scale fabrication methods. In this light, fully inkjet printed …

Purpose The on-going transition of societies and economies toward different organizational
paradigms deeply informed by digital technologies is at the very center of current debates, …

Purpose Patients with somatostatin receptor subtype 2-positive metastasised neuroendocrine
tumours can be treated with [ 177 Lu-DOTA 0 ,Tyr 3 ]octreotate. Some use octreotide as …

Quality of life (QOL) is an important outcome in cancer therapy. In this study, we investigated
the QOL and symptoms after [ 177 Lu-DOTA 0 ,Tyr 3 ]octreotate ( 177 Lu-octreotate) therapy …